E-LIB Suche - Ergebnisse für: Mario Sznol

1

A crisis in clinical research:

Hong, David S ; LoRusso, Patricia ; Sznol, Mario
Journal for ImmunoTherapy of Cancer. 12 (2024) 7 - p. e008520 , 2024

Link: https://doi.org/10.1136/..

2

Causes of death and patterns of metastatic disease at the e..:

Lee, Daniel Y. ; McNamara, Madeline ; Yang, Alexander...
Pigment Cell & Melanoma Research. , 2024

Link: https://doi.org/10.1111/..

3

Interferon-stimulated neutrophils as a predictor of immunot..:

Benguigui, Madeleine ; Cooper, Tim J. ; Kalkar, Prajakta...
Cancer Cell. 42 (2024) 2 - p. 253-265.e12 , 2024

Link: https://doi.org/10.1016/..

4

Phase I studies of davoceticept (ALPN-202), a PD-L1-depende..:

Davar, Diwakar ; Cavalcante, Ludimila ; Lakhani, Nehal...
Journal for ImmunoTherapy of Cancer. 12 (2024) 8 - p. e009474 , 2024

Link: https://doi.org/10.1136/..

5

Immunotherapy utilization in stage IIIA melanoma: less may ..:

Frey, Alexander E. ; Kerekes, Daniel M. ; Khan, Sajid A....
Frontiers in Oncology. 14 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

6

Outcomes With Combination Pembrolizumab and Axitinib in Sec..:

Dizman, Nazli ; Austin, Matthew ; Considine, Bryden...
Clinical Genitourinary Cancer. 21 (2023) 2 - p. 221-229 , 2023

Link: https://doi.org/10.1016/..

7

First-in-human phase Ib trial of M9241 (NHS-IL12) plus avel..:

Strauss, Julius ; Deville, Jean-Laurent ; Sznol, Mario...
Journal for ImmunoTherapy of Cancer. 11 (2023) 5 - p. e005813 , 2023

Link: https://doi.org/10.1136/..

8

Evaluating the medical management of locally advanced and m..:

Belzer, Annika ; Pach, Jolanta ; Mortlock, Ryland D....
JAAD International. 11 (2023) - p. 174-175 , 2023

Link: https://doi.org/10.1016/..

9

Determinants of overall survival in patients with metastati..:

Demkowicz, Patrick ; Pointdujour‐Lim, Renelle ; Miguez, Sofia...
Cancer. 129 (2023) 20 - p. 3275-3286 , 2023

Link: https://doi.org/10.1002/..

10

CD4 T cells and toxicity from immune checkpoint blockade:

Earland, Noah ; Zhang, Wubing ; Usmani, Abul...
Immunological Reviews. 318 (2023) 1 - p. 96-109 , 2023

Link: https://doi.org/10.1111/..

11

A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab..:

Weiss, Sarah A. ; Sznol, Mario ; Shaheen, Montaser...
Clinical Cancer Research. 30 (2023) 1 - p. 74-81 , 2023

Link: https://doi.org/10.1158/..

12

Teaching an old dog new tricks: re-engineering IL-2 for imm..:

Sznol, Mario ; Rizvi, Naiyer
Journal for ImmunoTherapy of Cancer. 11 (2023) 1 - p. e006346 , 2023

Link: https://doi.org/10.1136/..

13

Clinical Predictors of Survival in Patients With BRAFV600-M..:

Kahn, Adriana M ; Perry, Curtis J ; Etts, Katrina..
The Oncologist. 29 (2023) 4 - p. e507-e513 , 2023

Link: https://doi.org/10.1093/..

14

A bedside to bench study of anti-PD-1, anti-CD40, and anti-..:

Djureinovic, Dijana ; Weiss, Sarah A. ; Krykbaeva, Irina...
Molecular Cancer. 22 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

15

Bempegaldesleukin plus nivolumab in first-line renal cell c..:

Tannir, Nizar M ; Cho, Daniel C ; Diab, Adi...
Journal for ImmunoTherapy of Cancer. 10 (2022) 4 - p. e004419 , 2022

Link: https://doi.org/10.1136/..